Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Return on Assets: 2020-2021

Historic Return on Assets for Black Diamond Therapeutics (BDTX) over the last 1 years, with Sep 2021 value amounting to -0.37%.

  • Black Diamond Therapeutics' Return on Assets fell 21.00% to -0.37% in Q3 2021 from the same period last year, while for Sep 2021 it was -0.37%, marking a year-over-year decrease of 21.00%. This contributed to the annual value of -0.27% for FY2020, which is 1.00% up from last year.
  • Black Diamond Therapeutics' Return on Assets amounted to -0.37% in Q3 2021, which was down 33.10% from -0.28% recorded in Q2 2021.
  • Black Diamond Therapeutics' Return on Assets' 5-year high stood at -0.13% during Q2 2020, with a 5-year trough of -0.37% in Q3 2021.
  • For the 2-year period, Black Diamond Therapeutics' Return on Assets averaged around -0.21%, with its median value being -0.18% (2020).
  • Data for Black Diamond Therapeutics' Return on Assets shows a maximum YoY fell of 21bps (in 2021) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Return on Assets (Quarterly) stood at -0.20% in 2020, then fell by 21bps to -0.37% in 2021.
  • Its Return on Assets was -0.37% in Q3 2021, compared to -0.28% in Q2 2021 and -0.20% in Q4 2020.